Recent Finacing
Recent Raise
Ternary Therapeutics is a London-based biotechnology company developing an AI-powered platform to design molecular glue therapeutics that induce protein–protein interactions to target previously undruggable diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
